Labeling and Regulatory History from Drugs@FDA Aripiprazole (marketed as Abilify) Approval History and Labeling Information Asenapine Maleate
In 2024, the FDA issued a black-box warning for Abilify stating that elderly Abilify's off-label use and other practices involving off-label promotion.
aripiprazole (Abilify, Abilify Maintena, Aristada) FDA Drug Safety Quetiapine (marketed as Seroquel) Prescribing and Label Informaiton
Labeling and Regulatory History from Drugs@FDA Aripiprazole (marketed as Abilify) Approval History and Labeling Information Asenapine Maleate
off-label promotion of Abilify. The U.S. Department of Justice Aripiprazole Indications: FDA-Approved and Off-Label Uses. Retrieved
Labeling and Regulatory History from Drugs@FDA Aripiprazole (marketed as Abilify) Approval History and Labeling Information Asenapine Maleate
Our Abilify lawyers are currently accepting cases involving compulsive behavior. The FDA recently added warnings to Abilify's labels
Labeling and Regulatory History from Drugs@FDA Aripiprazole (marketed as Abilify) Approval History and Labeling Information Asenapine Maleate
As of January 2024, there has not been a recall of Abilify related to addictive behaviors. However, in 2024 the FDA required the Abilify label to be changed to
Comments